fr 41565 has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Singh, SM; Sodhi, A | 1 |
| Lenz, B; Long, C; Phillips, H; Schneider, M; Talmadge, JE | 1 |
| Ivanitskaia, LP; Khurnova, LM | 1 |
1 review(s) available for fr 41565 and Experimental Neoplasms
| Article | Year |
|---|---|
[Low-molecular weight immunomodulators of microbial origin].
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Diaminopimelic Acid; Glycine; Guinea Pigs; Immunologic Deficiency Syndromes; Leucine; Mice; Molecular Weight; Neoplasms, Experimental; Oligopeptides | 1989 |
2 other study(ies) available for fr 41565 and Experimental Neoplasms
| Article | Year |
|---|---|
Effect of tumor cells on the activation of murine lymphocytes and macrophages by cisplatin and FK565.
Topics: Adjuvants, Immunologic; Animals; Cisplatin; Female; Lymphocyte Activation; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitrogen; Oligopeptides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Immunomodulatory and therapeutic properties of FK-565 in mice.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Cell Line; Cytotoxicity, Immunologic; Killer Cells, Natural; Lymphocyte Culture Test, Mixed; Macrophage Activation; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Oligopeptides; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 1989 |